The US and Switzerland have agreed to a Mutual Recognition Agreement (MRA) on pharmaceutical Good Manufacturing Practices (GMP). The US Food and Drug Administration (FDA) and the Swiss Agency for Therapeutic Products (Swissmedic) will be able to utilize each other’s GMP audits of pharmaceutical manufacturing facilities under the terms of the agreement with the Swiss […]

The post United States-Switzerland Strike A Drug Inspection Accord first appeared on World Pharma Today.